Extreme poverty is negatively impacting clinical trial subjects in 3rd world countries in many ways. Using disruptive technology concepts, not only empowers these subjects to access important platforms and patient support programs, but also increases the overall safety of the trial. The ability to reverse charge any costs associated with accessing ePRO platforms (or similar) will enable study coordinators to keep a close eye on the patient population between visits.
Adriaan Kruger have 20 years’ experience in Enterprise Application Development and implementation including 7+ years’ experience in Clinical Data Management and Drug Development digitization. He led and managed many global and regional multinational projects and teams in various capacities. He was recruited out of varsity to join a small Oracle Consulting start-up in 2008 which was later acquired by EOH Holdings Limited (listed on Johannesburg Stock Exchange). Within EOH I ended up working as a Divisional Head across various verticals, including Oracle Enterprise Application and Engineered Solutions. Today He lead a group of exceptionally gifted team members at nuvoteQ.io (a software company I co-founded in 2014) where we are empowering our customers to digitize their industries (mainly life sciences) in a simplified, yet innovative manner. He is passionate about start-ups and disruptive technologies shaping the world and fascinated by the gifted individuals who make it happen.